Johnson & Johnson (NYSE:JNJ) announced today that it plans to increase its biopharmaceutical manufacturing presence in North Carolina. The company committed $2 billion toward a 160,000+-square-foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. Its commitment spans the next 10 years, expanding its U.S. manufacturing capacity and creating approximately… The post Johnson & Johnson commits $2B investment to North Caro...| Pharmaceutical Processing World
ChemPartner today announced plans for its strategic expansion in the U.S. with a new Boston Center of Excellence. Located at 480 Arsenal way in Watertown, Massachusetts, just outside of Boston, the new R&D site will commence operations on Sept. 10. The Shanghai-based CRO and CDMO plans to use the site to provide discovery and preclinical… The post Pharma CDMO ChemPartner expands with new R&D facility in Boston appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
AbbVie (NYSE:ABBV) announced today that it invested $195 million to expand domestic active pharmaceutical ingredient (API) production. The company’s investment comes in its North Chicago, Illinois, plant to advance its U.S. API manufacturing. This expansion comes as part of AbbVie’s commitment to invest more than $10 billion in the U.S. to broadly support innovation and… The post AbbVie to invest $195M in U.S. active pharmaceutical ingredient manufacturing appeared first on Pharmaceutic...| Pharmaceutical Processing World
Bionova Scientific, a subsidiary of Asahi Kasei, today announced the opening of a new plasmid DNA (pDNA) production facility in The Woodlands, Texas. The 10,000-square-foot, state-of-the-art development and production facility sits less than 30 miles north of Houston. It designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. pDNA… The post Bionova opens new plasmid DNA materials production plant in Texas appeared first on Pharmaceutical ...| Pharmaceutical Processing World
ProBio announced today that it launched new cGMP adeno-associated virus (AAV) manufacturing services in Hopewell, New Jersey.| Pharmaceutical Processing World
Germ-free eggs from Ireland’s Ovagen Group could cut raw material needs for yellow fever vaccine production by more than 90%, according to new data from a U.K. study. Researchers at the Pirbright Institute found that Ovagen’s embryonated chicken eggs yielded an average 7,606 doses of yellow fever 17D vaccine per egg, compared with 422 doses… The post Ovagen germ-free eggs yield up to 7,600 yellow fever vaccine doses each appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
ArtBio announced today that it closed a $132 million Series B funding round to advance its development of alpha radioligand therapies (ARTs).| Pharmaceutical Processing World
Thermo Fisher Scientific recently announced plans to acquire Sanofi’s sterile manufacturing site in Ridgefield, New Jersey, and continue producing a portfolio of Sanofi therapies there while opening the facility to additional pharmaceutical and biotech customers. The plant performs sterile fill-finish and packaging, and has more than 200 employees, all of whom will join Thermo Fisher… The post Thermo Fisher, Sanofi expand drug manufacturing partnership appeared first on Pharmaceutical Pro...| Pharmaceutical Processing World
Varda Space Industries recently announced a $187 million fundraise, bringing the total amount of money raised to $329 million for the El Segundo, California–based startup. Natural Capital and Shrug Capital led the Series C round, with participation from Founders Fund, Peter Thiel, Khosla Ventures, Caffeinated Capital, Lux Capital, and Also Capital. Varda Space Industries’ goal… The post Varda raises $187M Series C for drug manufacturing in space appeared first on Pharmaceutical Processi...| Pharmaceutical Processing World
London-based Hikma has already spent more than $4 billion over the past 15 years to build out its U.S. presence, first established in 1991.| Pharmaceutical Processing World
By Sean Whooley | February 26, 2025| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it made a $4.5 billion investment to create the Lilly Medicine Foundry in Indiana.| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced that it plans to invest $3 billion in the expansion of its manufacturing facility in Kenosha County, Wisconsin.| Pharmaceutical Processing World
Eli Lilly's investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020.| Pharmaceutical Processing World
Purdue University, Eli Lilly and Merck have launched the Young Institute Pharmaceutical Manufacturing Consortium.| Pharmaceutical Processing World